Stock PHARMASSET, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Pharmasset, Inc.

Equities

US71715N1063

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Pharmasset, Inc.

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pharmasset, Inc. : Gilead Sciences Completes Acquisition of Pharmasset, Inc.
BU
Pharmasset, Inc. : Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc.
BU
Pharmasset, Inc. : Pharmasset Announces Intent to Amend QUANTUM Trial
PR
Pharmasset, Inc. : Ryan & Maniskas, LLP Announces Investigation of Pharmasset, Inc.
BU
Pharmasset, Inc. : Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pharmasset, Inc.
BU
Pharmasset, Inc. : Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion
BU
Pharmasset, Inc. : Pharmasset Reports Fiscal Year End 2011 Financial Results
PU
Pharmasset, Inc. : Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
PR
Pharmasset, Inc. : Pharmasset to Present at Credit Suisse First Boston Healthcare Conference
PR
Pharmasset, Inc. : Pharmasset to Webcast an Investor Event from the AASLD Meeting
PU
Pharmasset, Inc. : Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
PR
Pharmasset, Inc. : Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C
PU
PHARMASSE : Pharmasset to Present at Two Upcoming Conferences
PR
PHARMASSE : Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
PR
PHARMASSE : Pharmasset Announces 91% SVR12 From the PROTON Trial in Subjects With Hepatitis C Genotype 1
PU
PHARMASSE : Pharmasset to Present at Two Upcoming Conferences
PR
PHARMASSE : PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
PR
PHARMASSE : Pharmasset Announces Two-for-One Forward Stock Split
PR
PHARMASSE : Pharmasset to Present at Canaccord Genuity Growth Conference
PR
PHARMASSE : Pharmasset Reports Fiscal Third Quarter 2011 Financial Results
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Pharmasset, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW